YOU ARE ABOUT TO LEAVE A GSK WEBSITE

You are about to leave a GSK website. By clicking this link, you will be taken to a website that is independent from GSK. The site you are linking to is not controlled or endorsed by GSK, and GSK is not responsible for its content.

You are using an unsupported browser.

Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Sorry, your browser window is too small.

Some features of this site may not function properly. For optimal user experience, please view this site in a larger browser window.

For US Residents
Select Language
English Español
Prescribing Information Visit US Healthcare Professional Site Visit US HCP Site
USXF DTC Branded with Claims
Tell us what you are looking for in the search box.
SIGN UP TO LEARN MORE
  • About RSV
  • About AREXVY
  • Side Effects
  • Get AREXVY
    • Find AREXVY
    • Cost & Coverage
  • FAQs
  • Sign Up
    • Sign Up to Learn More
    • Sign Up for Reminders
  • Select Language
    • English
    • Español
  • Visit US HCP Site
WHAT IS AREXVY & SAFETY INFO
What Is AREXVY?

What Is AREXVY?

AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in:

  • people 60 years of age and older;
  • people 50 through 59 years of age at increased risk for LRTD caused by RSV.

Important Safety Information

  • You should not receive AREXVY if you are allergic to any of its ingredients

AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in:

  • people 60 years of age and older;
  • people 50 through 59 years of age at increased risk for LRTD caused by RSV.

AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in:

  • people 60 years of age and older;
  • people 50 through 59 years of age at increased risk for LRTD caused by RSV.
Important Safety Information
Important Safety Information - Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum.
  • You should not receive AREXVY if you are allergic to any of its ingredients
  • A study suggests an increased risk of Guillain-Barré syndrome after vaccination with AREXVY
  • Fainting can happen after getting injectable vaccines, including AREXVY. Precautions should be taken to avoid injury due to fainting
  • Some people with weakened immune systems may have reduced immune responses to AREXVY
  • You should not receive AREXVY if you are allergic to any of its ingredients
  • A study suggests an increased risk of Guillain-Barré syndrome after vaccination with AREXVY
  • Fainting can happen after getting injectable vaccines, including AREXVY. Precautions should be taken to avoid injury due to fainting
  • Some people with weakened immune systems may have reduced immune responses to AREXVY
  • The most common side effects are pain, redness, and swelling at the injection site, fatigue, muscle pain, headache, and joint pain
  • Tell your healthcare provider if you are pregnant or breastfeeding
  • Vaccination with AREXVY may not result in protection of all vaccine recipients
  • Ask your healthcare provider about the risks and benefits of AREXVY. Only a healthcare provider can decide if AREXVY is right for you

Please see full Prescribing Information.

You are encouraged to report vaccine adverse events to the US Department of Health and Human Services. Visit www.vaers.hhs.gov to file a report or call 1-800-822-7967. You may also file a report with GSK at gsk.public.reportum.com or 1-888-825-5249.

GSK Help Center logo

Explore the GSK Help Center website to find customer service support and contact information.

Contact Us

GSK For You logo

If you have questions about how to access your GSK medication or need cost information, visit gskforyou.com or call 1-866-GSK-FOR-U (1-866-475-3678).

Utility Links
Legal Notice
Privacy Notice
Consumer Health Privacy
Interest-Based Ads
Contact Us
Medicine Savings
Unsubscribe